Product Liability Litigation Playbook: Pros And Cons For Pharma

Drug makers are winning cases by getting expert testimony tossed, but the AndroGel verdict shows how narrow claims can benefit plaintiffs. The Pink Sheet offers a look at drugs in multidistrict litigation from Abilify to Zoloft.

Gavel with stethoscope

Johnson & Johnson's recent experience shows how uncertain product liability litigation is for drug makers. After winning jury verdicts in three Xarelto (rivaroxaban) bellwether trials, the company was hit with a $417m verdict in a talcum powder lawsuit last month.

Despite the divergent outcomes in personal injury complaints for J&J, pharma companies are seeing some positive trends. One significant development...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet